Clinical Trial Update: A 2 Part Study Examining Doses Of GSK961081 In Healthy Volunteers And Then In COPD Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update on doses of GSK961081, studied first in healthy volunteers and then in COPD patients, with the study status showing as completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• GSK961081

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 2 | Status: COMPLETED